About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,472 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,472 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2581-2600 of 22,472 trials

Enrolling by invitationTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)To evaluate the long-term safety and tolerability of sibeprenlimab in subjects with IgANNCT05248659·Birmingham, Alabama and 157 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

RecruitingStudy to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionThe purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian cancer with cyclin E1…NCT07214779·Anchorage, Alaska and 197 others

RecruitingMYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to…NCT05564390·Birmingham, Alabama and 359 others

Active not recruitingA Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 AntibodyThis is a Phase 1/2 study of HST-1011, a CBL-B inhibitor, being developed for the treatment of patients with advanced solid tumors, who relapsed while on or are refractory to…NCT05662397·Sarasota, Florida and 13 others

CompletedEvaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout PatientsThe purpose of this study is to determine whether arhalofenate is effective in preventing flares and reducing serum uric acid in gout patients.NCT02063997·Birmingham, Alabama and 55 others

TerminatedOpen Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple SclerosisThe purpose of this study is to further evaluate the safety and efficacy of Tovaxin in the treatment of relapsing forms of multiple sclerosis.NCT00595920·Cullman, Alabama and 26 others

CompletedStudy of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseThe purpose of this trial is to understand if saxagliptin is more effective than placebo as a treatment for type 2 diabetic subjects who are not controlled with diet and exerciseNCT00316082·Columbiana, Alabama and 73 others

RecruitingA Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerThis study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic CancerNCT07644559·Los Angeles, California and 37 others

RecruitingSafety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related ComorbiditiesObesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher.NCT07752979·Pelham, Alabama and 62 others

CompletedBirinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine TherapyThis is a dose escalation followed by dose expansion study of TL32711 in combination with 5-Azacitidine in subjects with Myelodysplastic syndrome who are naïve, have relapsed or…NCT01828346·Glendale, Arizona and 6 others

RecruitingRegistry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEntsA multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by…NCT06893588·Burbank, California and 15 others

TerminatedA Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell LymphomaThis study will include participants with relapsed/refractory (R/R) Multiple Myeloma (MM). MM is a type of cancer of the blood.NCT05121103·Duarte, California and 7 others

UnknownVentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal TrialThe purpose of this study is to evaluate the safety and effectiveness of VentrAssistTM LVAD in individuals who are awaiting heart transplants.NCT00483197·Birmingham, Alabama and 28 others

CompletedPhase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With RadiotherapyM3814 was an investigational drug that is being evaluated for the treatment of participants with locally advanced tumors.NCT02516813·Fresno, California and 25 others

CompletedStudy of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail PsoriasisThis purpose of this study was to demonstrate the efficacy of secukinumab versus placebo on nail psoriasis and to assess long-term efficacy, safety and tolerability of secukinumab.NCT01807520·Birmingham, Alabama and 39 others

CompletedGemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesThe goal of this clinical research study is to find the highest tolerated dose of gemcitabine that can be given with busulfan and melphalan.NCT00410982·Houston, Texas

CompletedNUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainEvaluate how NUCYNTA (tapentadol) immediate release (IR) compares with oxycodone IR in the treatment of acute low back pain.NCT00986180·Mobile, Alabama and 73 others

RecruitingA Study of HS-20110 in Participants With Advanced Solid TumorsThis is an open-label, multicenter study to evaluate the safety and tolerability of HS-20110 in participants with advanced solid malignant tumorsNCT06892379·Tamarac, Florida and 7 others

Active not recruitingRadioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)This trial aims to improve hepatocellular carcinoma (HCC) tumor responses in patients undergoing Y90 radioembolization by using personalized dosimetry as part of treatment…NCT03896646·Houston, Texas

CompletedFive Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)This is a Phase II, non-randomized, open-label, multi-center study conducted in the USA.NCT00867113·La Jolla, California and 20 others

PreviousPage 130 of 1124Next

in Houston

Heart Diseasein Houston